Early intervention in neurodegenerative diseases, such as Alzheimer’s, offers the potential to slow or prevent disease progression, and increase success rates for clinical development.
The biotechnology industry is undergoing a profound digital transformation, with artificial intelligence (AI), cloud computing and real-time analytics reshaping drug discovery, personalised medicine and healthcare delivery.